5 Key Facts About CKD Treatment

5 Key Facts About CKD Treatment

If you have been diagnosed with Chronic Kidney Disease (CKD), your first question is likely: “Can it be cured?”

The short answer is no, not usually. Whilst CKD is a lifelong condition, it can almost always be stabilised. With modern medical intervention, many patients successfully prevent the progression to kidney failure.

Below is a comprehensive guide to the latest treatments, based around the 5 most critical pillars of care.

5 Key Facts Summary

1. Not everyone needs intensive treatment: Mild CKD (Stages 1–3a) is often managed through lifestyle and monitoring by your GP.

2. Blood Pressure is Priority #1: Keeping your BP under 130/80 is the single most effective way to protect your kidneys.

3. New Drug Classes: SGLT2 inhibitors and ACE/ARBs are ‘game-changers’ for reducing protein leak (proteinuria).

4. Specific Causes Matter: Treatments for autoimmune kidney disease (e.g. Glomerulonephritis, GN) differ vastly from treatments for a physical blockage (obstruction to the urinary tract).

5. Anaemia is Treatable: Tiredness in CKD is often due to a lack of EPO (erythropoietin), which can be easily corrected with injections or tablets.

1. Not Everyone Needs Intensive Treatment (Understanding Stages)

Doctors determine your treatment plan based on your eGFR (Estimated Glomerular Filtration Rate), which measures how well your kidneys filter waste.

Mild CKD (Stages 1–3a) is often managed entirely through lifestyle adjustments and routine primary care monitoring.

2. Blood Pressure Control is Priority #1

Keeping your blood pressure under control is the single most effective way to protect your kidney filters from physical scarring and progressive damage.

• The Target: Aim for less than 130/80 (or less than 120/70 if you have Diabetes).

• ACE Inhibitors & ARBs: First-line medications like Ramipril or Losartan are the gold standard. They don’t just lower systemic blood pressure; they specifically decrease the pressure inside the kidney filters and reduce harmful protein leak (proteinuria).

• The Lifestyle Foundation: A low-salt diet is essential to help these blood pressure medications work efficiently. Additionally, most patients are prescribed statins to mitigate the cardiovascular risks associated with kidney issues, alongside strict smoking cessation to stop accelerated kidney scarring.

3. New Drug Classes are Total Game-Changers

The introduction of SGLT2 inhibitors has fundamentally shifted the outlook for kidney preservation.

Originally developed to manage type 2 diabetes, medications like Dapagliflozin are now a foundational standard of care for CKD.

They assist the kidneys in excreting excess sugar and salt via urine.

This action takes immediate mechanical stress off the nephrons (filtering units), significantly slowing down the decline of kidney function even in patients who do not have diabetes.

4. Specific Causes Fundamentally Change Your Treatment

CKD is not a diagnosis in itself. It is a clinical syndrome caused by a variety of underlying diseases (causes), your therapy must be targeted directly at the root cause:

• Diabetes: Prioritises strict blood glucose control alongside kidney-protective blood pressure regimens.

• Glomerulonephritis (GN): Because this involves an autoimmune attack on the kidneys, management requires targeted immunosuppressants like Prednisolone or Rituximab.

• Polycystic Kidney Disease (PKD): Highly specific therapies, such as Tolvaptan, may be used to actively slow down cyst growth.

• Obstruction: If structural blockages like a prostate issue or kidney stone are impairing urine flow, surgical options or a catheter can frequently reverse acute kidney damage.

• Renovascualar Disease: Focuses heavily on managing (unclogging) the renal arteries that deliver blood supply to the organs.

5. Advanced Care Involves Planning & Taking Control

As kidney function drops below 30% (Stages 4 and 5), specialist intervention pivots toward managing structural complications and looking ahead.

• Complication Management: Anaemia-driven fatigue—caused by a lack of the natural hormone EPO (erythropoietin)—is easily corrected with targeted injections or tablets once haemoglobin falls below 100 g/L. Renal bone disease is managed with calcium acetate to prevent bone brittleness, while bicarbonate tablets keep blood acid levels balanced.

• Preparing for the Future: Stage 4 care includes timely discussions around access surgery (creating a fistula for dialysis) or an active transplant referral. Living donation from a loved one remains the most successful long-term option.

• Empowering Your Data: You can take direct charge of your outcomes. Track your own eGFR and ACR (albumin-to-creatinine ratio) trends online using portals like the PKB (Patients Know Best) website. Explicitly ask your GP: “Am I on an ACE inhibitor or an SGLT2 inhibitor?” and always double-check with your clinical team that you are actively on the Transplant Waiting List if you have been deemed eligible.

Expert Review: This article was reviewed by Dr. Vicki Ayub, Consultant Nephrologist, UHCW Coventry.